Recent News
On February 26, 2026 the Board authorized an increase to the share‑repurchase program by up to $400 million; the company also set its 2026 virtual annual meeting date and published a public product roadmap in March highlighting map-centric discovery features, hotel booking tests, and a U.S. Health Center for sexual health and wellness resources.
Technical Analysis
ADX sits at 25.24, indicating a strong trend environment and signaling that recent directional readings carry conviction for price action rather than noise.
Directional indicators favor upside: DI+ at 25.09 shows an increasing trajectory while DI‑ at 13.04 trends lower, which aligns with bullish directional strength and raises the probability that near-term moves will favor the long side of recent ranges.
MACD reads 0.32 with the MACD line above the 0.23 signal line and the MACD trend increasing; that cross above the signal line constitutes a bullish momentum confirmation that supports further short‑term upside continuation.
MRO registers 11.91 with a dip‑and‑reversal pattern; the positive MRO indicates the current price sits above the internal target framework and therefore introduces a higher probability of consolidation or mean reversion toward fair value after short‑term advances.
RSI at 55.32 and rising points to constructive momentum without overbought extremes, which leaves room for additional upside before momentum exhaustion becomes a primary constraint.
Price sits at $13.45, above the 20‑day average of $12.66 and the 12‑day EMA of $12.90 (both trending up), but below the 200‑day average of $14.06; the configuration implies near‑term bullishness inside a longer‑term mean that still sits higher, so upside may encounter the 200‑day average as resistance while shorter MAs provide support.
Bands and volatility: price currently near the upper Bollinger band (1× std dev $13.26, 2× $13.86) with 42‑day volatility muted; this positioning supports a scenario of continuation toward the upper band unless MRO‑driven reversion forces pullback to the $12.6–$12.9 EMA band.
Fundamental Analysis
Profitability: EBIT of $31,368,000 and EBITDA of $32,421,000 produce an operating margin of 24.9%. That EBIT margin at 24.9% sits below the industry peer mean of 34.07% and the industry peer median of 34.63% but well above the peer low; QoQ EBIT margin declined by 35.35% and YoY margin change registers −120.42%, underscoring compressed sequential margin dynamics relative to recent periods.
Revenue and growth: total revenue $125,974,000 with revenue growth reported at 8.82% and revenue growth year‑over‑year at −5.05% (both figures provided); the mixed growth metrics indicate recent top‑line momentum in some reporting windows but a negative YoY headline that warrants monitoring for sustainability.
Liquidity and cash flow: cash and short‑term investments total $87,045,000 with a cash ratio of 1.02 and current ratio of 1.96, reflecting immediate liquidity coverage above one turn. Operating cash flow stands at $24,758,000 and free cash flow $21,856,000, yielding a free cash flow yield of 0.97%, which comes in above the industry peer mean of 0.58%.
Leverage and balance sheet: total debt $400,588,000 produces debt‑to‑assets of 75.44% and debt‑to‑equity of 8.52. Debt metrics sit materially above the industry peer mean for debt‑to‑assets (12.98%) but remain within the industry peer range ceiling; interest coverage at 5.67x provides near‑term coverage for current interest obligations but highlights sensitivity to operating earnings swings.
Returns and efficiency: return on equity reads 43.10% while return on assets stands at 4.18%; asset turnover 0.26 and receivables days roughly 46 indicate modest monetization of the asset base. Research and development expense at $14,612,000 points to ongoing product investment aligned with the roadmap initiatives.
Earnings and estimates: reported EPS $0.11 versus estimate $0.12 produced an EPS surprise of −8.33%. Forward EPS sits at $0.19 with a forward P/E of 74.05, implying elevated expectations relative to trailing results.
Valuation context: price‑to‑earnings 121.25x, price‑to‑sales 17.81x and enterprise multiple near 78.9x all reflect a stretched multiple set relative to typical interactive media comparables; WMDST values the stock as over‑valued given the combination of leverage, the premium multiples, and the gap between near‑term momentum and underlying recurring profitability.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-03-02 |
| NEXT REPORT DATE: | 2026-06-01 |
| CASH FLOW | Begin Period Cash Flow | $ 6.9 M |
| Operating Cash Flow | $ 24.8 M | |
| Capital Expenditures | $ -2.90 M | |
| Change In Working Capital | $ -21.25 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 80.7 M | |
| End Period Cash Flow | $ 87.7 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 126.0 M | |
| Forward Revenue | $ 54.6 M | |
| COSTS | ||
| Cost Of Revenue | $ 31.7 M | |
| Depreciation | $ 1.1 M | |
| Depreciation and Amortization | $ 1.1 M | |
| Research and Development | $ 14.6 M | |
| Total Operating Expenses | $ 94.7 M | |
| PROFITABILITY | ||
| Gross Profit | $ 94.3 M | |
| EBITDA | $ 32.4 M | |
| EBIT | $ 31.4 M | |
| Operating Income | $ 31.3 M | |
| Interest Income | — | |
| Interest Expense | $ 5.5 M | |
| Net Interest Income | $ -5.54 M | |
| Income Before Tax | $ 25.8 M | |
| Tax Provision | $ 5.6 M | |
| Tax Rate | 21.57 % | |
| Net Income | $ 20.3 M | |
| Net Income From Continuing Operations | $ 20.3 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.12 | |
| EPS Actual | $ 0.11 | |
| EPS Difference | $ -0.01 | |
| EPS Surprise | -8.333 % | |
| Forward EPS | $ 0.19 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 531.0 M | |
| Intangible Assets | $ 354.5 M | |
| Net Tangible Assets | $ -307.53 M | |
| Total Current Assets | $ 166.0 M | |
| Cash and Short-Term Investments | $ 87.0 M | |
| Cash | $ 87.0 M | |
| Net Receivables | $ 67.9 M | |
| Inventory | — | |
| Long-Term Investments | $ 4.6 M | |
| LIABILITIES | ||
| Accounts Payable | $ 1.7 M | |
| Short-Term Debt | $ 20.0 M | |
| Total Current Liabilities | $ 84.9 M | |
| Net Debt | $ 308.8 M | |
| Total Debt | $ 400.6 M | |
| Total Liabilities | $ 484.0 M | |
| EQUITY | ||
| Total Equity | $ 47.0 M | |
| Retained Earnings | $ -97.06 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 0.25 | |
| Shares Outstanding | 185.035 M | |
| Revenue Per-Share | $ 0.68 | |
| VALUATION | Market Capitalization | $ 2.2 B |
| Enterprise Value | $ 2.6 B | |
| Enterprise Multiple | 78.869 | |
| Enterprise Multiple QoQ | 17.8 % | |
| Enterprise Multiple YoY | -402.007 % | |
| Enterprise Multiple IPRWA | high: 172.49 median: 80.873 GRND: 78.869 mean: 77.175 low: -131.235 |
|
| EV/R | 20.298 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 11.297 | |
| Asset To Liability | 1.097 | |
| Debt To Capital | 0.895 | |
| Debt To Assets | 0.754 | |
| Debt To Assets QoQ | 16.97 % | |
| Debt To Assets YoY | 2309.326 % | |
| Debt To Assets IPRWA | high: 0.935 GRND: 0.754 mean: 0.13 median: 0.1 low: 0.001 |
|
| Debt To Equity | 8.522 | |
| Debt To Equity QoQ | 113.485 % | |
| Debt To Equity YoY | -7574.836 % | |
| Debt To Equity IPRWA | GRND: 8.522 high: 2.068 mean: 0.203 median: 0.143 low: -0.935 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 47.727 | |
| Price To Book QoQ | 21.256 % | |
| Price To Book YoY | -306.589 % | |
| Price To Book IPRWA | GRND: 47.727 high: 12.969 median: 9.015 mean: 8.41 low: -3.34 |
|
| Price To Earnings (P/E) | 121.245 | |
| Price To Earnings QoQ | 28.156 % | |
| Price To Earnings YoY | -594.764 % | |
| Price To Earnings IPRWA | high: 160.153 GRND: 121.245 mean: 99.872 median: 59.058 low: -47.921 |
|
| PE/G Ratio | -2.945 | |
| Price To Sales (P/S) | 17.809 | |
| Price To Sales QoQ | -26.178 % | |
| Price To Sales YoY | -42.804 % | |
| Price To Sales IPRWA | high: 27.747 median: 27.747 mean: 23.467 GRND: 17.809 low: 0.189 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 74.048 | |
| Forward PE/G | -1.798 | |
| Forward P/S | 41.052 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -3.362 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.26 | |
| Asset Turnover Ratio QoQ | 10.676 % | |
| Asset Turnover Ratio YoY | 24.415 % | |
| Asset Turnover Ratio IPRWA | high: 0.615 GRND: 0.26 median: 0.195 mean: 0.192 low: 0.002 |
|
| Receivables Turnover | 1.987 | |
| Receivables Turnover Ratio QoQ | -0.505 % | |
| Receivables Turnover Ratio YoY | -4.736 % | |
| Receivables Turnover Ratio IPRWA | high: 6.923 mean: 2.165 GRND: 1.987 median: 1.897 low: 0.163 |
|
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | 45.912 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 36.795 | |
| Cash Conversion Cycle Days QoQ | 2.496 % | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 97.243 GRND: 36.795 mean: -1.581 median: -2.112 low: -294.971 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 1.553 | |
| CapEx To Revenue | -0.023 | |
| CapEx To Depreciation | -2.756 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 422.9 M | |
| Net Invested Capital | $ 442.9 M | |
| Invested Capital | $ 442.9 M | |
| Net Tangible Assets | $ -307.53 M | |
| Net Working Capital | $ 81.1 M | |
| LIQUIDITY | ||
| Cash Ratio | 1.025 | |
| Current Ratio | 1.955 | |
| Current Ratio QoQ | 137.458 % | |
| Current Ratio YoY | 13.329 % | |
| Current Ratio IPRWA | high: 7.741 mean: 2.091 median: 2.005 GRND: 1.955 low: 0.114 |
|
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 12.356 | |
| Cost Of Debt | 1.27 % | |
| Interest Coverage Ratio | 5.666 | |
| Interest Coverage Ratio QoQ | -40.678 % | |
| Interest Coverage Ratio YoY | -125.527 % | |
| Interest Coverage Ratio IPRWA | high: 238.758 median: 123.621 mean: 111.25 GRND: 5.666 low: -107.388 |
|
| Operating Cash Flow Ratio | 0.115 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 9.117 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 20.912 % | |
| Revenue Growth | 8.818 % | |
| Revenue Growth QoQ | -20.401 % | |
| Revenue Growth YoY | -5.05 % | |
| Revenue Growth IPRWA | high: 44.631 % mean: 11.842 % median: 9.633 % GRND: 8.818 % low: -27.55 % |
|
| Earnings Growth | -41.176 % | |
| Earnings Growth QoQ | -141.176 % | |
| Earnings Growth YoY | -95.309 % | |
| Earnings Growth IPRWA | high: 300.0 % mean: 2.162 % median: -8.333 % GRND: -41.176 % low: -143.243 % |
|
| MARGINS | ||
| Gross Margin | 74.844 % | |
| Gross Margin QoQ | -0.233 % | |
| Gross Margin YoY | -0.697 % | |
| Gross Margin IPRWA | high: 100.0 % GRND: 74.844 % mean: 62.848 % median: 59.793 % low: 5.477 % |
|
| EBIT Margin | 24.9 % | |
| EBIT Margin QoQ | -35.35 % | |
| EBIT Margin YoY | -120.424 % | |
| EBIT Margin IPRWA | high: 107.803 % median: 34.627 % mean: 34.073 % GRND: 24.9 % low: -89.445 % |
|
| Return On Sales (ROS) | 24.854 % | |
| Return On Sales QoQ | -36.402 % | |
| Return On Sales YoY | -120.386 % | |
| Return On Sales IPRWA | high: 85.377 % median: 31.568 % mean: 31.202 % GRND: 24.854 % low: -77.331 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 21.9 M | |
| Free Cash Flow Yield | 0.974 % | |
| Free Cash Flow Yield QoQ | -46.921 % | |
| Free Cash Flow Yield YoY | 4.731 % | |
| Free Cash Flow Yield IPRWA | high: 19.19 % GRND: 0.974 % median: 0.656 % mean: 0.575 % low: -24.396 % |
|
| Free Cash Growth | -57.348 % | |
| Free Cash Growth QoQ | -243.863 % | |
| Free Cash Growth YoY | -4167.234 % | |
| Free Cash Growth IPRWA | high: 452.0 % mean: 7.667 % median: 0.368 % GRND: -57.348 % low: -588.0 % |
|
| Free Cash To Net Income | 1.079 | |
| Cash Flow Margin | 7.742 % | |
| Cash Flow To Earnings | 0.481 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.04 | |
| Return On Assets (ROA) | 4.176 % | |
| Return On Assets QoQ | -33.173 % | |
| Return On Assets YoY | -115.77 % | |
| Return On Assets IPRWA | high: 13.424 % median: 6.089 % mean: 5.796 % GRND: 4.176 % low: -27.097 % |
|
| Return On Capital Employed (ROCE) | 7.031 % | |
| Return On Equity (ROE) | 0.431 | |
| Return On Equity QoQ | -0.817 % | |
| Return On Equity YoY | -54.213 % | |
| Return On Equity IPRWA | GRND: 0.431 high: 0.175 median: 0.083 mean: 0.082 low: -0.443 |
|
| DuPont ROE | 34.351 % | |
| Return On Invested Capital (ROIC) | 5.555 % | |
| Return On Invested Capital QoQ | -43.409 % | |
| Return On Invested Capital YoY | -97.93 % | |
| Return On Invested Capital IPRWA | high: 12.209 % median: 7.518 % mean: 7.094 % GRND: 5.555 % low: -22.288 % |
|